Colorectal cancer drug may cause permanent nerve damage
- Details
- Category: Research
Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.
Genetically modified 'serial killer' T cells obliterate tumors in leukemia patients
- Details
- Category: Research
In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells.
CONTRACT's Questionnaire to Analyse and Improve Informed Consent in Clinical Trials
- Details
- Category: Research
In the frame of the European Project CONTRACT, which aims at analysing, improving and harmonising "informed consent" across Europe a questionnaire has been set up which will analyse the current situation concerning the legal, ethical, technical and clinical handling of consent, mainly in European projects dealing with vulnerable patient groups.
IMI announces a new total of 23 unique projects to boost drug innovation
- Details
- Category: Research
The Innovative Medicines Initiative (IMI), currently the largest public-private partnership in the biopharmaceutical sector, launches its second wave of research projects which address key areas including cancer, immune-mediated diseases, infectious disorders and electronic health.
Which Pharma Product Websites are Driving Consumers to the Doctor to Request Prescriptions?
- Details
- Category: Research
Pharmaceutical and healthcare market research company Manhattan Research recently released the ePharma Consumer® v10.0 study, which explores the online behaviors of ePharma Consumers, or U.S. consumers using the Internet for prescription drug information.
IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion
- Details
- Category: Research
The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011, to US$880 billion, compared with a 4-5 percent pace this year, according to IMS Health. The forecast, included in the latest release of IMS Market Prognosis™, is the leading annual industry indicator of market dynamics and therapy performance.
First DataBank's FIRSTLight Goes Live
- Details
- Category: Research
First DataBank's new online medicines reference tool, FIRSTLight, is now live and First DataBank is offering a free extended trial until the end of January 2011. FIRSTLight provides instant access to reliable medicines information, empowering clinicians and supporting safer, faster clinical decision making.
More Pharma News ...
- New technique to speed up drug development
- Reasons Why mHealth Apps Matters for Pharma
- Europeans are Interested in Online Patient Education Programs
- Millions unite for diabetes awareness on World Diabetes Day 2010
- Study finds association between painkillers in pregnancy and male reproductive problems
- Cost Benefits and Considerable Scientific Expertise Provide China Strategic Advantage
- The Growing Consumer Demand for Online Health Video